FLEMING, PAUL,HARRIMAN, GERALDINE C. B.,SHI, ZHAN,CHEN, SHAOWU
申请号：
AU2012203029
公开号：
AU2012203029A1
申请日:
2012.05.23
申请国别(地区):
AU
年份:
2012
代理人:
摘要：
C: NHPonblI)CC R'j I2 _ .gI) OC.21AIv Il2 The invention relates to compounds represented by Structural Formula 1, which can bind to CCR9 receptors and block the binding of a ligand (e.g., TECK) to the receptors. The invention also relates to a method of inhibiting a function of CCR9, and to the use coiIpounds represented by Structural Formula I in research, therapeutic, prophylactic and diagnostic methods.
